Anticipated
Administration of betamethasone
🌸 The client is 30 weeks gestation, so fetal lung maturity is still developing.
🌸 Betamethasone is anticipated because antepartum bleeding can increase the risk for preterm birth.
🌸 Corticosteroids help accelerate fetal lung maturity and reduce complications such as respiratory distress syndrome.
🌸 This medication is commonly given between 24 and 34 weeks gestation when preterm delivery is possible.
🌸 Because the client has ongoing bright red bleeding, preparation for possible early delivery is appropriate.
Administration of IV fluids
🌸IV fluids are anticipated because the client has ongoing vaginal bleeding.
🌸Fluid therapy helps maintain maternal circulating volume and supports uteroplacental perfusion.
🌸Even though current vital signs are stable, bleeding can worsen quickly in placenta previa or other antepartum bleeding conditions.
🌸IV access also allows rapid medication or blood product administration if the client becomes unstable.
🌸Maintaining maternal perfusion is essential because fetal oxygenation depends on maternal circulation.
Laboratory testing: CBC, Blood Type & Rh, Coagulation Studies
🌸Laboratory testing is anticipated because the client has moderate bright red bleeding at 30 weeks gestation.
🌸A CBC helps evaluate hemoglobin, hematocrit, and platelet status.
🌸Blood type and Rh testing are important in case blood products or Rh immune globulin are needed.
🌸Coagulation studies help assess bleeding risk and detect clotting complications.
🌸These labs provide baseline data and guide urgent treatment if bleeding increases.
Abdominal ultrasound
🌸Abdominal ultrasound is anticipated because the client has painless, bright red bleeding, which is suspicious for placenta previa.
🌸Ultrasound helps locate the placenta and determine whether it is near or covering the cervical opening.
🌸This client has not had an ultrasound during pregnancy, making placental location unknown.
🌸Ultrasound is a safe, noninvasive way to evaluate the cause of bleeding before any cervical examination.
🌸Confirming placenta location is essential because cervical manipulation can cause severe hemorrhage if previa is present.
Continuous monitoring of FHR
🌸Continuous fetal heart rate monitoring is anticipated because maternal bleeding can reduce uteroplacental perfusion.
🌸FHR assessment helps identify fetal distress early if bleeding worsens.
🌸The current FHR of 148/min with moderate variability is reassuring, but ongoing bleeding requires continued monitoring.
🌸Continuous monitoring also helps evaluate contraction activity and fetal response.
🌸This intervention supports early recognition of maternal or fetal compromise.
Contraindicated
Digital cervical exam to assess dilation and effacement
🌸A digital cervical exam is contraindicated until placenta previa is ruled out by ultrasound.
🌸If the placenta is covering or near the cervix, a digital exam can trigger massive hemorrhage.
Placement of an internal fetal spiral electrode
🌸Internal fetal spiral electrode placement is contraindicated with unexplained vaginal bleeding and suspected placenta previa.
🌸It requires cervical access and can increase bleeding or introduce infection risk.